File:GSK_logo_2022.svg · Wikimedia Commons · See Wikimedia Commons
Also known as GlaxoSmithKline plc, Glaxo Smith Kline, GlaxoSmithKline, Glaxo, GSK plc
British multinational pharmaceutical and biotechnology company
OverviewAI-generated
GSK, legally known as GSK PLC, is a pharmaceutical preparations company established in 2000. The organization is headquartered in London, United Kingdom, and operates as an active entity within that jurisdiction. It employs 99,541 people and is categorized as both a company and a funder.
The firm trades on the NYSE and OTC exchanges under the tickers GSK and GLAXF. Its official website is gsk.com, and it describes its mission as uniting science, technology, and talent to address disease. GSK is referenced by 2,048 other encyclopedia articles.
Synthesized by Vinony from 35 facts across 6 sources: Wikidata, Firecrawl, GLEIF, SEC EDGAR, ROR, Vinony graph. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Company
GSK, GLAXF- Industry
- Pharmaceutical Preparations
- Exchange
- NYSE, OTC
- State of incorporation
- X0
- Entity type
- other
- Latest filing
- 6-K · 2026-06-01
- Jurisdiction
- GB
- Headquarters
- LONDON, GB
Research organization · ROR
- Type
- Company, Funder
- Founded
- 2000
- Location
- London, United Kingdom
- Also known as
- GSK
- Status
- Active
GRID grid.418236.a · ISNI 0000 0001 2162 0389
Official website
Link to the official site · 6,361 chars · not written by Vinony
~40 min read
Encyclopedic overview
GSK plc (an abbreviation of its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
Excerpted from Wikipedia’s “GSK” article, available under the CC BY-SA 4.0 licence.